Explore our blogs on various markets

August 2, 2025 | Thousand Oaks, CA — Amgen has officially announced Meritide (formerly MariTide, maridebart cafraglutide), its groundbreaking investigational therapy for obesity, type 2 diabetes, and related cardiometabolic conditions, marking a bold step forward in the global fight against metabolic disease.. A breakthrough in obesity and diabetes management. In results from its Phase 2 clinical trial, Meritide showed strong and steady weight loss in adults living with obesity, both with and without type 2 diabetes...

Eli Lilly has officially acquired Verve Therapeutics, a pioneering biotech company specializing in in vivo gene editing for cardiovascular disease. The deal, announced on July 25, 2025, is valued at up to $1.3 billion. . It includes an upfront cash payment of $10.50 per share and a contingent value right (CVR) that may provide an additional $3.00 per share if Verve’s lead candidate reaches a U.S...

On July 22, 2025, Sanofi announced a definitive agreement to acquire Vicebio, a clinical-stage biotechnology company developing next-generation respiratory vaccines. The deal is valued at $1.6 billion and includes a $1.15 billion upfront payment with up to $450 million in milestone-based payments. The acquisition aims to expand Sanofi’s respiratory vaccine portfolio through access to Vicebio’s proprietary Molecular Clamp technology....

Clinical development is a long and expensive process. It often takes years of planning, testing, and data collection to bring a new medicine to market. Even then, most clinical trials do not succeed...

Clinical trials help test if new medicines are safe and effective. But many trials fail to find enough people or keep them until the end. One reason is that trial designs often do not match what patients need or want....

Generative AI is transforming the way pharmaceutical companies operate. It helps teams discover drugs faster, write documents quicker, and find insights in huge amounts of data. Instead of doing everything manually, experts can now use GenAI to save time and focus on what matters most—patient care and innovation....

Summary:. Roche, one of the world’s biggest drugmakers, is thinking about selling its medicines directly to patients in the United States. The company’s CEO, Thomas Schinecker, said this plan could help reduce the high cost of prescription drugs in the country...

Roivant Sciences is developing brepocitinib, a new oral drug that blocks both TYK2 and JAK1. These proteins play a key role in autoimmune diseases like dermatomyositis and lupus. . Brepocitinib targets several harmful signals in the body, not just one, which may make it more effective than older treatments...

Summary. Roche has officially initiated the global rollout of Lunsumio® (mosunetuzumab) for the treatment of adult patients with third-line and beyond relapsed or refractory follicular lymphoma (FL). The fixed-duration, off-the-shelf, T-cell engaging bispecific antibody has already been commercially used in over 2,400 patients, according to company data, with significant adoption across major oncology markets....

Zomedica Pharmaceuticals has released a new and improved canine cortisol assay for its TRUFORMA point-of-care diagnostic platform. . The assay allows veterinarians to diagnose Cushing’s syndrome and Addison’s disease within minutes, using a simple in-clinic process. . Previously, such diagnoses required shipping blood samples to external labs and waiting one or two days for results...